Ron Dirks is a molecular biologist and CEO of Future Genomics Technologies B.V. In 2008, Ron joined ZF-screens B.V., where he was managing director and together with his colleagues developed zebrafish-based screening pipelines for pharmaceutical drugs, worked on artificial reproduction of European eel, and developed new genomics solutions based on second and third generation sequencing platforms. During his academic career at Radboud University and University of Wisconsin, Ron worked on regulation of expression of cancer genes, embryonic development of the vertebrate eye, molecular regulation of the cellular stress response and developing transgenic animal models. In 2017, the genomics activities of ZF-screens moved to Future Genomics Technologies. Ron contributed to more than 90 peer-reviewed scientific papers.
Hans Jansen is an experienced molecular biologist who has worked on different topics such as gene promoters, plant embryogenesis, and early animal embryonic development. He joined ZF-screens in 2007 where he managed general lab affairs and introduced nanopore sequencing technology in 2014 before joining FG-Technologies in 2017.
Wouter Veneman joined Future Genomics Technologies in January 2019 as a scientist, after obtaining his PhD in Molecular Cell Biology from Leiden University. Wouter is responsible for method and protocol development in the field of Nextgen sequencing, in particular cutting-edge ONT long read sequencing.
Jane Segobola joined Future Genomics Technologies in December 2021 as a scientist and is responsible for execution of the planned projects. As part of her role, she also develops and supports initiatives, innovative and advanced genomic solutions. Jane holds a PhD in Biotechnology from the University of Pretoria in South Africa and is currently pursuing her MBA from The Hague University of Applied Sciences. She worked as a medical technician in the microbiology department of a human diagnostic laboratory (Ampath laboratories, in South Africa), where she was responsible for processing and analysing human samples. She was based at the CSIR as a PhD candidate where she gained biotechnology experience. Prior to joining FG-Technologies, she worked briefly at CapeBio technologies as a research and development scientist heading the R&D department, where she gained more experience in the field of genomics.